PL367941A1 - Leczenie lipodystrofii - Google Patents
Leczenie lipodystrofiiInfo
- Publication number
- PL367941A1 PL367941A1 PL02367941A PL36794102A PL367941A1 PL 367941 A1 PL367941 A1 PL 367941A1 PL 02367941 A PL02367941 A PL 02367941A PL 36794102 A PL36794102 A PL 36794102A PL 367941 A1 PL367941 A1 PL 367941A1
- Authority
- PL
- Poland
- Prior art keywords
- lipodystrophy
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0119460.4A GB0119460D0 (en) | 2001-08-09 | 2001-08-09 | The use of inhibitors of the renin-angiotensin system |
| PCT/GB2002/003639 WO2003013486A1 (en) | 2001-08-09 | 2002-08-07 | The treatment of lipodystrophy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL367941A1 true PL367941A1 (pl) | 2005-03-07 |
Family
ID=9920113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02367941A PL367941A1 (pl) | 2001-08-09 | 2002-08-07 | Leczenie lipodystrofii |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7022693B2 (pl) |
| EP (1) | EP1414421B1 (pl) |
| JP (1) | JP2005527462A (pl) |
| KR (1) | KR20040054665A (pl) |
| CN (1) | CN1541094A (pl) |
| AP (1) | AP1731A (pl) |
| AT (1) | ATE411012T1 (pl) |
| AU (1) | AU2002319535B2 (pl) |
| CA (1) | CA2456549A1 (pl) |
| DE (1) | DE60229398D1 (pl) |
| DK (1) | DK1414421T3 (pl) |
| ES (1) | ES2332884T3 (pl) |
| GB (1) | GB0119460D0 (pl) |
| HU (1) | HUP0401041A3 (pl) |
| MX (1) | MXPA04001174A (pl) |
| NO (1) | NO20040561L (pl) |
| PL (1) | PL367941A1 (pl) |
| WO (1) | WO2003013486A1 (pl) |
| ZA (1) | ZA200400887B (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100028439A1 (en) * | 2005-05-23 | 2010-02-04 | Elan Pharma International Limited | Nanoparticulate stabilized anti-hypertensive compositions |
| US20070066512A1 (en) * | 2005-09-12 | 2007-03-22 | Dominique Verhelle | Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0635263A3 (en) * | 1993-06-28 | 1995-09-27 | American Cyanamid Co | Angiotensin II antagonists (AII) as inhibitors of the growth of adipose tissue. |
| DE69830069T3 (de) | 1997-10-17 | 2012-02-09 | Ark Therapeutics Ltd. | Verwendung von hemmern des renin-angiotensin systems zur behandlung von hypoxie oder verringertem stoffwechsel |
| US7045532B2 (en) * | 1999-04-30 | 2006-05-16 | Millennium Pharmaceuticals, Inc. | ACE-2 modulating compounds and methods of use thereof |
| WO2001015674A2 (en) * | 1999-08-30 | 2001-03-08 | Aventis Pharma Deutschland Gmbh | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
| US20020013334A1 (en) | 2000-06-15 | 2002-01-31 | Robl Jeffrey A. | HMG-CoA reductase inhibitors and method |
-
2001
- 2001-08-09 GB GBGB0119460.4A patent/GB0119460D0/en not_active Ceased
-
2002
- 2002-08-07 DE DE60229398T patent/DE60229398D1/de not_active Expired - Fee Related
- 2002-08-07 CN CNA028156129A patent/CN1541094A/zh active Pending
- 2002-08-07 US US10/485,018 patent/US7022693B2/en not_active Expired - Fee Related
- 2002-08-07 HU HU0401041A patent/HUP0401041A3/hu unknown
- 2002-08-07 AP APAP/P/2004/002980A patent/AP1731A/en active
- 2002-08-07 MX MXPA04001174A patent/MXPA04001174A/es active IP Right Grant
- 2002-08-07 ES ES02749123T patent/ES2332884T3/es not_active Expired - Lifetime
- 2002-08-07 AT AT02749123T patent/ATE411012T1/de not_active IP Right Cessation
- 2002-08-07 DK DK02749123T patent/DK1414421T3/da active
- 2002-08-07 PL PL02367941A patent/PL367941A1/pl not_active Application Discontinuation
- 2002-08-07 KR KR10-2004-7001416A patent/KR20040054665A/ko not_active Application Discontinuation
- 2002-08-07 AU AU2002319535A patent/AU2002319535B2/en not_active Ceased
- 2002-08-07 JP JP2003518496A patent/JP2005527462A/ja active Pending
- 2002-08-07 WO PCT/GB2002/003639 patent/WO2003013486A1/en active IP Right Grant
- 2002-08-07 EP EP02749123A patent/EP1414421B1/en not_active Expired - Lifetime
- 2002-08-07 CA CA002456549A patent/CA2456549A1/en not_active Abandoned
-
2004
- 2004-02-03 ZA ZA200400887A patent/ZA200400887B/en unknown
- 2004-02-06 NO NO20040561A patent/NO20040561L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE411012T1 (de) | 2008-10-15 |
| GB0119460D0 (en) | 2001-10-03 |
| AU2002319535B2 (en) | 2005-01-06 |
| HUP0401041A2 (hu) | 2004-08-30 |
| JP2005527462A (ja) | 2005-09-15 |
| ES2332884T3 (es) | 2010-02-15 |
| WO2003013486A1 (en) | 2003-02-20 |
| DE60229398D1 (de) | 2008-11-27 |
| MXPA04001174A (es) | 2005-02-17 |
| NO20040561L (no) | 2004-03-23 |
| CN1541094A (zh) | 2004-10-27 |
| DK1414421T3 (da) | 2008-12-08 |
| HUP0401041A3 (en) | 2004-10-28 |
| CA2456549A1 (en) | 2003-02-20 |
| EP1414421B1 (en) | 2008-10-15 |
| US20040209941A1 (en) | 2004-10-21 |
| EP1414421A1 (en) | 2004-05-06 |
| AP2004002980A0 (en) | 2004-03-31 |
| AP1731A (en) | 2007-03-30 |
| US7022693B2 (en) | 2006-04-04 |
| ZA200400887B (en) | 2005-02-03 |
| KR20040054665A (ko) | 2004-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2393202B (en) | Methods of well treatment | |
| GB0113751D0 (en) | Surface treatment | |
| EP1390029A4 (en) | PHENYLINDOLES FOR THE TREATMENT OF HIV INFECTION | |
| GB0109087D0 (en) | Treatment of suspensions | |
| HUP0400609A3 (en) | Wet-skin treatment compositions | |
| GB0108671D0 (en) | Skin treatment | |
| EP1461027A4 (en) | TREATMENT OF NEOPLASIA | |
| GB0213869D0 (en) | The treatment of pain | |
| GB0124124D0 (en) | Methods of treatment | |
| GB0113910D0 (en) | Treatment of liquids | |
| GB0130763D0 (en) | Treatment methods | |
| PL367941A1 (pl) | Leczenie lipodystrofii | |
| GB0103031D0 (en) | Novel treatment | |
| IL161630A0 (en) | Methods of treating endometreosis | |
| IL158413A0 (en) | Treatment of adhd | |
| GB0130694D0 (en) | Treatment | |
| GB0120786D0 (en) | The treatment of IBD | |
| GB0120654D0 (en) | Treatment of anemia | |
| GB0109519D0 (en) | Nimico treatment | |
| GB0116837D0 (en) | Treatment | |
| GB0117425D0 (en) | Novel treatment | |
| GB0117419D0 (en) | Novel treatment | |
| GB0117307D0 (en) | Novel treatment | |
| GB0117303D0 (en) | Novel treatment | |
| EP1435940A4 (en) | TREATMENT OF SCLERODERMY |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |